GLORIA

GEOMAR Library Ocean Research Information Access

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    In: HPB, Elsevier BV, Vol. 12, No. 10 ( 2010-12), p. 657-663
    Type of Medium: Online Resource
    ISSN: 1365-182X
    Language: English
    Publisher: Elsevier BV
    Publication Date: 2010
    detail.hit.zdb_id: 2071267-4
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 2
    In: Liver Transplantation, Ovid Technologies (Wolters Kluwer Health), Vol. 23, No. 11 ( 2017-11), p. 1372-1383
    Abstract: Transplantation of liver grafts from donation after cardiac death (DCD) is limited. To identify barriers of DCD liver utilization, all active US liver transplant centers (n = 138) were surveyed, and the responses were compared with the United Network for Organ Sharing (UNOS) data. In total, 74 (54%) centers responded, and diversity in attitudes was observed, with many not using organ and/or recipient prognostic variables defined in prior studies and UNOS data analysis. Most centers (74%) believed lack of a system allowing a timely retransplant is a barrier to utilization. UNOS data demonstrated worse 1‐ and 5‐year patient survival (PS) and graft survival (GS) in DCD (PS, 86% and 64%; GS, 82% and 59%, respectively) versus donation after brain death (DBD) recipients (PS, 90% and 71%; GS, 88% and 69%, respectively). Donor alanine aminotransferase (ALT), recipient Model for End‐Stage Liver Disease (MELD), and cold ischemia time (CIT) significantly impacted DCD outcomes to a greater extent than DBD outcomes. At 3 years, relisting and retransplant rates were 7.9% and 4.6% higher in DCD recipients. To optimize outcome, our data support the use of DCD liver grafts with CIT 〈 6‐8 hours in patients with MELD ≤ 20. In conclusion, standardization of donor and recipient criteria, defining the impact of ischemic cholangiopathy, addressing donor hospital policies, and developing a strategy for timely retransplant may help to expand the use of these organs. Liver Transplantation 23 1372–1383 2017 AASLD.
    Type of Medium: Online Resource
    ISSN: 1527-6465 , 1527-6473
    Language: English
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date: 2017
    detail.hit.zdb_id: 2002186-0
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 3
    In: Andrologia, Hindawi Limited, Vol. 54, No. 1 ( 2022-02)
    Type of Medium: Online Resource
    ISSN: 0303-4569 , 1439-0272
    URL: Issue
    Language: English
    Publisher: Hindawi Limited
    Publication Date: 2022
    detail.hit.zdb_id: 2009045-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 4
    In: Reproductive Sciences, Springer Science and Business Media LLC, Vol. 29, No. 6 ( 2022-06), p. 1836-1843
    Abstract: We aimed to find a correlation between the intraoperative diameters of the seminiferous tubules evaluated at high magnification during micro-testicular sperm extraction (micro-TESE) and total motile sperm count (TMSC) in non-obstructive azoospermic (NOA) patients. Five hundred four consecutive NOA patients were included and underwent micro-TESE. The change in the mean TMSC and different seminiferous tubular diameters was of high statistical significance ( p   〈  0.001). It should be noted that the highest mean TMSC was reported in the dilated tubules (DTs) group followed by the other study groups 941.72 ± 196.97, 487.37 ± 443.57, and 34.54 ± 60.79, respectively. Furthermore, 21 naïve cases had dilated tubules (DTs) and 18 (85.7%) of them had shown eventful micro-TESE. Conversely, 186 naïve cases had slightly dilated tubules (SDTs), and 101 (54.3%) of them had eventful micro-TESE. Only 8 (24.25%) cases of the 33 cases had non dilated tubules (NDTs) and showed eventful micro-TESE. The frequency of intrasurgical seminiferous tubular diameter and micro-TESE outcome among the naïve cases had demonstrated a highly statistical significance ( p   〈  0.001). Interestingly, all salvaged cases (100%) with DTs and a previous eventful TESE had shown eventful TESE in the current study. The most dilated intrasurgical seminiferous tubular diameter is associated with the highest TMSC in NOA patients including SCO cases.
    Type of Medium: Online Resource
    ISSN: 1933-7191 , 1933-7205
    Language: English
    Publisher: Springer Science and Business Media LLC
    Publication Date: 2022
    detail.hit.zdb_id: 2266096-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 5
    In: Urologia Journal, SAGE Publications
    Abstract: We aimed to evaluate the effect of daily 5 mg tadalafil on the neutrophil/lymphocyte ratio (NLR) and the platelet/lymphocyte ratio (PLR) in patients with erectile dysfunction (ED). Patients and methods: 30 subjects with ED were given tadalafil as well as 30 subjects with ED who were not receiving tadalafil were recruited. 30 healthy individuals served as controls. Results: Receiver operating characteristic curve (ROC) showed that the best cut off point of pre-treatment and post treatment NLR in the ED treatment group was found 〈 1.51, 〈 1.51, sensitivity of 68.3%, 58.3%, specificity of 53.3%, 53.3%, lower bound of 0.558, 0.517, upper bound of 0.789, 0.757, total accuracy of 67.4%, 63.7% and p 0.003, 0.0025, respectively. Additionally, the best cut off point of pre-treatment and post treatment PLR in the ED treatment group was found 〈 5.89, 〈 5.99, sensitivity of 65%, 63.3%, specificity of 63.3%, 53.3%, lower bound of 0.515, 0.435, upper bound of 0.755, 0.687, total accuracy of 63.5%, 56.1% and p 0.027, 0.341, respectively. Conclusion: Daily 5 mg Tadalafil supplementation significantly improves erectile function through decreasing these markers as well as depression and anxiety.
    Type of Medium: Online Resource
    ISSN: 0391-5603 , 1724-6075
    Language: English
    Publisher: SAGE Publications
    Publication Date: 2024
    detail.hit.zdb_id: 2557852-2
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 6
    In: Andrology, Wiley, Vol. 11, No. 2 ( 2023-02), p. 307-315
    Abstract: Current studies have suggested a close link between nesfatin‐1, an appetite‐related neuropeptide and gonadal hormones. Objectives We investigated the association between nesfatin‐1 serum level and erectile dysfunction severity in men with diabetes as well as the generalized anxiety disorder‐7 questionnaire, the patient health questionnaire‐9, serum testosterone, kidney and liver functions, glycated haemoglobin and lipid profile. Materials and methods Seventy‐five participants between 30 and 60 years were enrolled, 25 erectile dysfunction patients with type 2 diabetes (group I), 21 with diabetes and preserved erectile function (group II) and 29 healthy controls (group III). Erectile dysfunction status and severity were determined by the Arabic version of the international index of erectile function‐5 for all the participants. Psychological wellbeing was checked by the generalized anxiety disorder‐7 questionnaire and the patient health questionnaire‐9. Finally, participants were evaluated for serum nesfatin‐1, serum testosterone, kidney and liver functions, glycated haemoglobin and lipid profile. Results Serum nesfatin‐1 levels were significantly lower in groups I and II compared to the controls. The international index of erectile function‐5 scores had shown significant correlations with serum nesfatin‐1, serum testosterone, generalized anxiety disorder‐7, patient health questionnaire‐9, diastolic blood pressure, glycated haemoglobin, triglycerides, creatinine and albumin/creatinine ratio. Receiver operating characteristic analysis revealed that serum nesfatin‐1 ≥ 0.62 ng/ml, serum testosterone ≥2.9 ng/ml, generalized anxiety disorder‐7 score ≥7.5, patient health questionnaire‐9 score ≥5, glycated hemoglobin ≥6.4%, triglycerides ≥ 144 mg/dl, creatinine ≥ 0.85 mg/dl and albumin/creatinine ratio ≥ 26.5 are useful predictors of erectile dysfunction in men with type 2 diabetes, and the area under the curve for those variables was respectively 0.83, 0.76, 1, 0.75, 0.88, 0.72, 0.67 and 0.77. Finally, a linear regression analysis revealed that generalized anxiety disorder‐7 was the only strong independent predictor of the international index of erectile function‐5 ( p   〈  0.001). Discussion and conclusion Nesfatin‐1 can be used as a biomarker for the severity of anxiety in erectile dysfunction patients with diabetes. Use of this molecule in treatment of diabetes and erectile dysfunction should be strengthened by larger studies. Psychiatric care must be offered to patients with diabetes and erectile dysfunction and low serum nesfatin‐1 as they experience intense anxiety and depression.
    Type of Medium: Online Resource
    ISSN: 2047-2919 , 2047-2927
    URL: Issue
    Language: English
    Publisher: Wiley
    Publication Date: 2023
    detail.hit.zdb_id: 2693844-3
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
  • 7
    In: Archivio Italiano di Urologia e Andrologia, PAGEPress Publications, ( 2023-09-05)
    Abstract: Introduction: Galectin-1 (Gal-1) and galectin-3 (Gal-3) are expressed by many immune cells and receive considerable attention in the context of immunity. We aimed to compare between seminal plasma and serum levels of Gal-1 and Gal-3 in azoospermic patients and fertile men. Materials and methods: This cross-sectional study was conducted at the andrology outpatient clinic from January (2022) to September (2022). A total of 90 participants were enrolled and divided into two equal groups: azoospermic and normal group. Semen analysis was done for all participants. Hormonal profile including FSH, LH, serum prolactin, total testosterone and estradiol was performed as well as assessment of serum and seminal levels of Gal-1 and Gal-3 by ELISA commercial kits. Finally, scrotal Duplex was done in standing and supine position. Results: Serum and seminal levels of Gal-1 and Gal-3 were statistically significant higher in azoospermic patients compared with normal individuals (p 〈 0.001 for all). In addition, in healthy individuals there were statistically significant positive correlations between serum levels of Gal-1 and age, FSH, LH levels (r = 0.296, p = 0.005; r = 0.333, p = 〈 0.001; r = 0.312, p = 0.003, respectively) and serum levels of Gal-2 and FSH and LH (r = 0.436, p 〈 0.001; r = 0.350, p 〈 0.001, respectively), whereas serum Gal-3 showed a borderline positive correlation with age (r = 0.2, p = 0.059). Additionally, statistically significant positive correlations between seminal levels of Gal-1 and Gal-3 and free testosterone in healthy individuals were reported (r = 0.205, p = 0.053; r = 0.219, p = 0.038, respectively). On the other hand, there were negative correlations between serum and seminal levels of Gal-1 and Gal-3, total and progressive sperm motility, sperm count and abnormal sperm forms in healthy individuals (r = -0.382, p 〈 0.001; r = -0.405, p 〈 0.001; r = -0.376, p 〈 0.001; r = -0.364, p 〈 0.001) (r = -0.394, p 〈 0.001; r = -0.467, p 〈 0.001; r = -0.413, p 〈 0.001; r = -0.433, p 〈 0.001); (r = -0.372, p 〈 0.001; r = -0.377, p 〈 0.001; r = -0.317, p = 0.002; r = -0.311, p = 0.003)(r = -0.445, p 〈 0.001; r = -0.498, p 〈 0.001; r = -0.453, p 〈 0.001; r = -0.463, p 〈 0.001, respectively). Furthermore, statistically significant positive correlations between serum levels of Gal-1 and Gal-3 and age in azoospermic patients were reported (r = 0.511, p 〈 0.001; r = 0.390, p = 0.008, respectively). On the other hand, there were negative correlations between seminal Gal-1 and estradiol (E2) and seminal Gal-3 and FSH and LH in azoospermic patients (r= -0.318, p = 0.033; r = -0.322, p = 0.031; r = -0.477, p 〈 0.001, respectively). Also, negative correlations between serum Gal-3 and total and free testosterone in azoospermic patients were detected (r = -0.396, p = 0.007; r = -0.375, p = 0.011, respectively). Conclusions: Elevated serum and seminal levels of Gal-1 and Gal-3 have detrimental effects on spermatogenesis. Furthermore, the current study demonstrated potential regulatory effects of reproductive hormones on Gal-1 and Gal-3. Thus, future studies are needed to confirm such findings.
    Type of Medium: Online Resource
    ISSN: 2282-4197 , 1124-3562
    Language: Unknown
    Publisher: PAGEPress Publications
    Publication Date: 2023
    detail.hit.zdb_id: 2811868-6
    Location Call Number Limitation Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...